Showing results (531-540 of 956) with videos related to
Sort By:
Pageof 96
Biological Psychiatry|March 15, 1990
Plasma GABA-like activity in response to ethanol challenge in men at high risk for alcoholismH B Moss, J K Yao, M Burns, et al.Journal of Virology|March 1, 1987
Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cellsS Martin, B Moss, P W Berman, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancerO Karlsson, T Edlund, J B Moss, et al.The Journal of Chemical Physics|September 11, 2007
Spectroscopy of the A(1B2)-X(1A1) transition of jet-cooled fluorobenzene: laser-induced fluorescence, dispersed fluorescence, and pathological Fermi resonancesPhillip Butler, David B Moss, Hongming Yin, et al.Vaccine|August 1, 1994
A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virusG Sutter, L S Wyatt, P L Foley, et al.Alcohol and Drug Research|January 1, 1987
Sex-differences in ethanol sensitivity and alcohol and aldehyde dehydrogenase activities in the Syrian hamsterH B Moss, R J Salin-Pascual, P Rathnagiri, et al.Antimicrobial Agents and Chemotherapy|January 27, 2016
Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One CenterDavid A Stevens, Richard B Moss, Cathy Hernandez, et al.Virology|June 23, 1997
The genome of molluscum contagiosum virus: analysis and comparison with other poxvirusesT G Senkevich, E V Koonin, J J Bugert, et al.Nature|April 10, 1986
Expression of the HTLV-III envelope gene by a recombinant vaccinia virusS Chakrabarti, M Robert-Guroff, F Wong-Staal, et al.Clinical Immunology (Orlando, Fla.)|August 23, 2021
Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patientsKavita Mathi, Yael Rosenberg-Hasson, Holden Maecker, et al.Pageof 96